|
|
 |
Mats Lidgard, Chairman
Lawyer, previous work includes responsibility for legal affairs, patents, and trademarks at the Pharmacia Group and Active Biotech. He has also been responsible for legal affairs, patents, trademarks and business development at SBL Vaccin. Presently board member of Probi AB and Synphora AB and chairman of Unitech Pharma AB.
|
|
|
|
 |
Prof. Karl-Olof Borg
Professor. Ph.D. in Pharmaceutical Science, member of the Board of a number of companies including 7TM Pharma A/S, BioInvent International AB Galenica AB, Chairman of the Board of Pharmexa A/S. Previously he has held positions as Research Director at Astra, Pharmacia and Active Biotech.
|
|
 |
Prof. Alf Lindberg
Professor. MD at the Karolinska Institute. Presently CEO of Nobel Web AB. Board member of Medivir AB, Catella Health Care AB, Pharmexa A/S, Proteome Sciences plc, Avant Immunotherapeutics Inc. Previously he has held positions as Vice President Research & Development at Aventis Pasteur and Wyeth and has been member of the Nobel Committe.
|
|
|
 |
Pär Thuresson
President and CEO of Arne Thuresson Byggmaterial AB, a Group consisting of six companies, where he is CEO and Chairman of the Board in all six. Member of the Board of Sävsjö Plåtindustri AB. He has served as Chaiman of the Board of Nordea Vällingby and Lunda Företagsgrupp and as a Board Member in Hårologi AB. Certified Executive by the Swedish Management Group.
|
|
|
 |
Associate Prof. Ulf Schröder
VP of R&D and CSO in Eurocine.
See under Management.
|
|
|
|
|
|
|
|